Catalyst

Slingshot members are tracking this event:

Cytokinetics Announces Start of Phase 1b Clinical Trial of CK-2127107 in Elderly Subjects With Limited Mobility

Source Link:
http://ir.cytokinetics.com/news-releases/news-release-details/cytokinetics-announces-start-phase-1b-clinical-trial-ck-2127107

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CYTK Community voting in process
ALPMY Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 29, 2017
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Ck-2127107, Physical Function
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.